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The lysosomal carboxypeptidase A, Cathepsin A (CathA), is a serine protease with two distinct functions. CathA protects 𝛽-
galactosidase and sialidase Neu1 against proteolytic degradation by forming a multienzyme complex and activates sialidase Neu1.
CathA deficiency causes the lysosomal storage disease, galactosialidosis. These patients present with a broad range of clinical
phenotypes, including growth retardation, and neurological deterioration along with the accumulation of the vasoactive peptide,
endothelin-1, in the brain. Previous in vitro studies have shown that CathA has specific activity against vasoactive peptides and
neuropeptides, including endothelin-1 and oxytocin. Amutantmousewith catalytically inactive CathA enzyme (𝐶𝑎𝑡ℎ𝐴𝑆190𝐴) shows
increased levels of endothelin-1. In the present study, we elucidated the involvement of CathA in learning and long-termmemory in
3-, 6-, and 12-month-old mice. Hippocampal endothelin-1 and oxytocin accumulated in 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice, which showed learning
impairments as well as long-term and spatial memory deficits compared with wild-type littermates, suggesting that CathA plays a
significant role in learning and in memory consolidation through its regulatory role in vasoactive peptide processing.
1. Introduction
Cathepsin A (CathA) is a ubiquitously expressed component
of a lysosomal multienzyme complex (LMC) with indepen-
dent protective and catalytic functions [1, 2]. CathA is a
member of the serine protease family of enzymes, with
carboxypeptidase activity at pH 5.5 and deamidase and
esterase activity at pH 7.0 [3]. CathA protects sialidase 1 (also
known as Neu1) and 𝛽-galactosidase (𝛽-Gal) glycosidases
against proteolytic degradation by the composition of the
LMCand activatesNeu1.The complex is unable to form in the
absence of CathA [4]. In vitro studies have shown that CathA
has catalytic activity against several vasoactive peptides,
including endothelin-1, angiotensin-1, and bradykinin, and
some neuropeptides, such as oxytocin and substance P [5].
Genetic mutations in the CathA gene are characterized by
the occurrence of the lysosomal storage disorder galactosiali-
dosis, which involves a secondary deficiency of Neu1 and 𝛽-
Gal [6]. It has also been demonstrated that CathA is involved
in the inactivation of the lysosome-associated membrane
protein type 2a (lamp2a) in chaperone-mediated autophagy
[7].
The effects of immunization to CathA on learning in
a rat model inspired us to investigate whether catalytically
inactive CathA has similar effects on behavior and memory
[8]. Although the𝐶𝑎𝑡ℎ𝐴−/− knockout mouse model presents
phenotypes similar to human patients with galactosialidosis,
severe symptoms arising due to the secondary deficiency
of Neu1 and 𝛽-Gal prevent the use of this mouse model
for behavioral analysis [9]. Therefore, in this study, we used
a previously generated 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 knock-in mouse model
with a mutation in the catalytic site. Although catalytic
enzyme activity is abolished in𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice, they are still
able to form the LMC and activate Neu1 [10].
In this study, we analyzed the performance of𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice in learning- and memory-based tasks at three different
ages. We observed decline in cognitive functions as well
as in learning and memory in 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice. After reveal-
ing the involvement of CathA in these behavioral changes,
we investigated the levels of endothelin-1 and oxytocin in the
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mouse brain. We demonstrated here for the first
time that the hippocampal region has highly elevated lev-
els of the vasoactive peptides: endothelin-1, angiotensin-I,
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and bradykinin. Our findings clearly indicate that the neu-
robehavioral alterations in these mice are likely the result of
impaired processing of the vasoactive peptides.
2. Methods
2.1. Animals. The generation of mice containing a Ser190Ala
point mutation in the CathA active site (𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 strain)
was previously described [10]. The original 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice
were provided by AV Pshezhetsky (University of Mon-
treal, Canada). 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice were mated with C57BL/6
strain for at least five generations to stabilize the genetic
background. Littermates were used as controls. Mice were
housed in an accredited vivarium at constant temperature
and humidity under 12 h light : dark cycle in accordance with
the animal center’s guidelines. Mice had free access to food
and water. Approval for the animal care and experiments was
granted by the Animal Care and Use Committee of the Izmir
Institute of Technology.
2.2. Genotyping. All mice were genotyped for the S190A
mutation using genomic DNA extracted from the tail. The
PCR for the mutation was performed as previously de-
scribed [10] with allele specific primers using 5󸀠-GGTGGC-
GGAGAACAATTATG-3󸀠 and 5󸀠-AACAGAAGTGGCACC-
CTGA C-3󸀠.
2.3. Behavioral Analysis
2.3.1. Passive Avoidance Test. Both male wild-type (𝑛 = 7)
and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 (𝑛 = 8) mice at 3, 6, and 12 months old
of age were subjected to the passive avoidance test. The test
was conducted as previously described [11, 12].The apparatus
consisted of a two-compartment box, a lit compartment
connected to a dark compartment by a guillotine door.When
the animal stepped into the dark compartment with all four
paws, the door was closed and a 0.2mA foot shock was
delivered for 1 s. The latency times for entering the dark
compartment were measured in the training test and in the
retention test 24 h later. The maximum entry latency allowed
in the retention session was 300 s. A Shut Avoid Vol. 1.8
Harvard apparatus was used for the experiment.
2.3.2. Morris Water Maze Test. The mice at 3, 6, and 12
months of age were subjected to the Morris water maze
test to examine their spatial learning ability. The test was
conducted as previously described [13]. Mice first received
a 3-day habituation period requiring them to swim (60 s)
to a visible platform located in a circular tank (diameter,
140 cm; depth, 45 cm) filled with water (22∘C) made opaque
with powderedmilk.Distal visual cues andplatform locations
were then switched, the platform was submerged (1 cm),
and 5 days of trials with the hidden platform ensued. Two
hours following hidden platform testing, all mice were given
a probe trial (60 s) in which the time spent to reach the
target, distance travelled to the target zone, and proximity
to the target were recorded. In the hidden platform test,
mice were given three trials of 90 s to find the platform
(maximum intertrial interval of 45min), being guided to and
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Figure 1: 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice 3, 6, and 12 months old performed
significantly worse than their aged-matched wild-type littermates in
a passive avoidance task. Latencies to enter the dark compartment on
the test day are shown. If mice did not enter the dark compartment
within 600 s, a latency time of 600 s was recorded. The data are
presented as the mean ± standard error of the mean (SEM); ∗𝑝 <
0.05.
allowed to stay on the platform for 5 s on the first day if they
exceeded the given time. Measurements were acquired with
a Sony camera (model SSC-G18) centrally positioned above
the water tank. Behavioral differences were analyzed using
the Panlab SMART Video Tracking System v0.3 (Harvard
Apparatus). Animals were allowed to dry under heat lamp
after each trial to avoid hypothermia, and all experiments
were started at the same time each day.
2.4. Immunohistochemistry. For immunohistochemical anal-
ysis, mice were anesthetized, and transcardiac perfusion was
initiated with phosphate-buffered saline (PBS) followed by
4% paraformaldehyde in PBS. Brain tissues from 3-, 6-,
and 12-month-old mice were removed and placed in the
same fixative overnight at 4∘C and then treated sequentially
with 10%, 20%, and 30% sucrose in PBS overnight at 4∘C.
Brains were embedded in OCT and kept at −80∘C until
further use. The tissue was coronally sectioned (10 𝜇m thick)
and collected onto gelatin-coated slides at −20∘C using
Leica cryostat (CM1850-UV). Tissue sections were stored
at −80∘C, unless they were immediately used for further
immunostaining procedures. The endothelin-1 and oxytocin
peptide immunostaining was conducted as described in
their product data sheets. Primary antibodies (rabbit anti-
endothelin, 1 : 750, Cat. number ab113697, Abcam, and rabbit
anti-oxytocin, 1 : 500, Cat. number ab2078, Abcam) and
secondary Alexa-Fluor 488 (Cat. number ab150077, Abcam)
were used for immunostaining. Imageswere obtainedwith an
Olympus BX53 microscope.
2.5. Statistical Analysis. All data were processed and analyzed
using Excel (Microsoft) software. Quantification of peptide
accumulation in hippocampal areas was performed using Fiji
software [14]. Statistical analyses with respect to genotype in
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Figure 2: Learning and memory is impaired in 3-month-old 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice. Comparison of Morris water maze test results for 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice and their littermates at 3 months of age. (a) Average escape latency. (b) Distance moved before reaching the platform. (c) Proximity of
the mice to target in the visible platform test (days 1–3) and in the hidden platform test (days 4–8). Graph shows average time or distance ±
SEM.
the same age group of animals in the passive avoidance exper-
iments were tested by two-sample 𝑡-tests. Quantification and
analysis of water maze data were conducted using the video
tracking system recording as previously described. For each
acquisition trial, the latency (i.e., time in seconds to reach the
platform), distance travelled to the platform, and proximity
of the animal’s position to the goal were measured. Results
obtained from the water maze were graphed using a trial
version of GraphPad Prism 7. Potential group differences with
respect to age and genotype were tested by factorial analysis
of variance.
3. Results and Discussion
3.1. CathAEnzymatic Deficiency Effects onCognitive Function.
The effect of CathA catalytic deficiency and subsequent
vasoactive peptide accumulation on memory was investi-
gated using the passive avoidance test (Figure 1). Compared
with that of their wild-type littermates,𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice took
significantly less time to reenter the dark compartment on the
test day at 3 months (wild-type: 300 s; 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴: 213.96 s
± 27.48; 𝑝 = 0.02; 𝑛 = 6 for both conditions), 6 months
(wild-type: 300 s; 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴: 236.08 ± 29.46 s; 𝑝 = 0.04;
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Figure 3: Learning and memory is impaired in 6-month-old 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice. Comparison of Morris water maze test results for 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice andwild-type littermates at 6months of age. (a) Average escape latency. (b)Distance travelled before reaching the platform. (c) Proximity
of the mice to target in the visible (days 1–3) and in the hidden platform (days 4–8) tests. Graph shows average time or distance ± SEM.
𝑛 = 8 for both conditions), and 12 months of age (wild-type:
300 s; 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴: 207.25 ± 46.93 s; 𝑝 = 0.04, 𝑛 = 8 for both
conditions). Mice in the wild-type groups at all ages tested
did not enter the dark compartment on test day after having
previously received foot shock in that compartment, whereas
the 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice reentered the chamber, showing the
same deterioration inmemory function across all age groups.
3.2. CathA Enzymatic Deficiency Effects on Spatial Learning
and Memory. Three-month-old 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice displayed
spatial learning and memory deficits in the Morris water
maze task. Wild-type mice learned to use the visual clues to
quickly reach the visible escape platform in the first 3 days,
whereas 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice took a longer time to swim toward
the platform. Both groups initially had difficulty finding
the exact location of the platform once it was submerged
beneath the opaque water starting on day 4. However, both
groups quickly improved in their ability to find the plat-
form. Although wild-type mice oriented themselves better
as the daily trials progressed, the ability of 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice
appeared to decrease over time (𝐹(1.269) = 5.97; 𝑝 = 0.01)
(Figure 2(a)). In addition to having shorter escape latencies,
the wild-type group learned shorter paths to the platform
than the 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice in the first 3 days of training
(Figure 2(b)). Overall, 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice swam significantly
longer distances than wild-type mice did searching for the
platform (𝐹(1.269) = 8.06; 𝑝 = 0.005). Proximity to the target
measurements also supported that wild-type mice oriented
themselves in the pool so that they were significantly closer
to the platform in their search (𝐹(1.251) = 16.25, 𝑝 < 0.0001;
wild-type (𝑛 = 7) and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴, 𝑛 = 8; Figure 2(c)).
In 6-month-old animals, wild-type and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice
showed a parallel learning pattern but a different learning
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Figure 4: Learning andmemory is impaired in 12-month-old𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice. Comparison ofMorris water maze test results for𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice and their wild-type littermates at 12 months of age. (a) Average escape latency. (b) Distance travelled before reaching the platform.
(c) Proximity of mice to target in the visible (days 1–3) and in the hidden platform (days 4–8) tests. Graph shows average time or distance ±
SEM.
pace. All mice gave similar cognitive reactions to changes
of the distal clues. However, 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice adapted more
slowly than wild-type controls to changing visual patterns
(𝐹(1.346) = 8.40, 𝑝 = 0.003; Figure 3(a)). The average distance
wild-type mice swam to find the platform was significantly
less than that for their 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 littermates (𝐹(1.341) =
10.47, 𝑝 = 0.001; Figure 3(b)). The proximity to the platform
measurements demonstrated that wild-type animals used
distal clues more efficiently than 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice did to
stay nearer to the platform (𝐹(1.382) = 20.69, 𝑝 < 0.0001;
Figure 3(c)).
At 12 months of age, the escape latency for both groups
over the first 3 days of the experiment continuously decreased
compared with that of the previous day. The wild-type group
adapted better than 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice did to the submerged
platform on day 4. After this point, although the escape
latency scores for the 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice improved until day
8, they were consistently lower than those for the wild-type
group (𝐹(1.417) = 7.90, 𝑝 = 0.005; Figure 4(a)). The 12-
month-old wild-type mice swam shorter distance than their
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 counterparts on each day. After day 4, wild-
type mice swam direct paths to the platform, whereas their
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 littermates swam significantly longer distances
to reach the platform (𝐹(1.413) = 21.44, 𝑝 < 0.0001;
Figure 4(b)). Despite the proximity results indicating that
wild-type and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice swam nearly equal distances
from the platform, overall, wild-type mice had significantly
better scores in the proximity analysis (𝐹(1.436) = 3.98 𝑝 =
0.04; Figure 4(c)). A probe trial with the platform removed
was conducted after animals completed the sessions on
day 8 to determine whether the animals found platform
location by orienting themselves relative to environmental
cues or by coincidence. In this probe trial, both traditional
measures of time spent within the platform zone and total
distance moved within the platform zone and a relatively
new and widely accepted measure of proximity to the goal
6 Behavioural Neurology
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Figure 5: Probe trial in 3-, 6-, and 12-month-old mice. Graph shows relative time spent in the platform area after the platform was removed
on day 8. Only the animals that swam on all 8 days were used for the experiment. Wild-type mice were normalized to their 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
counterparts.
were analyzed. The analysis of the latency within the zone
showed that 3-, 6-, and 12-month-old wild-type mice spent
more time than their 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 littermates in the platform
zone (Figure 5(a)). The analysis of distance travelled within
the zone also showed that 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice swam shorter
distance in the platform zone than their wild-type coun-
terparts did (Figure 5(b)). In addition to these traditional
methods, themeasure of proximity during their search for the
platform location indicated that wild-type mice spent more
of their time closer to the platform position than 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice did (Figure 5(c)). These differences were not due to
motor function changes, as assessed by rotarod tests (data
not shown), in which 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice performed as well
as their wild-type littermates at 3 and 6 months of age and
significantly better than their counterparts at 12 months of
age. Based on this as well as the probe trial results, we
concluded that 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice 3–12 months of age have a
learning disability and impaired spatial memory.
3.3. Immunohistochemistry. To understand the reasons un-
derlying the behavioral deficits observed in𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice,
we characterized the distribution and accumulation of the
vasoactive peptides endothelin-1 and oxytocin, which are
endogenous substrates for the CathA enzyme. We found
that CathA enzyme deficient 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice displayed
significantly more endothelin-1 accumulation at 3, 6, and
12 months of age than their wild-type mice littermates
(Figure 6). Quantification of the fluorescent intensity indi-
cated that accumulation of endothelin-1 was significantly
increased at various times in entire hippocampal region of the
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mouse brain compared with that of their wild-
type littermates at 3 (∗∗∗𝑝 = 0.004), 6 (∗∗𝑝 = 0.01), and 12
(∗𝑝 = 0.05) months of age (Figure 7(a)). Significant increases
were observed in the CA2 region of 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice at 3
months (∗𝑝 = 0.04; Figure 7(b)) and 12 months (∗𝑝 = 0.05;
Figure 7(c)) of age and in the CA3 region at 6 months (∗∗𝑝 =
0.008; Figure 7(d)).
Analysis of the oxytocin distribution indicated a clear
accumulation of oxytocin in 3-, 6-, and 12-month-old
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice (Figures 8(b), 8(d), and 8(f)) compared
with that in their wild-type littermates (Figures 8(a), 8(c),
and 8(e)). The quantification results showed significantly
Behavioural Neurology 7
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Figure 6: Hippocampal endothelin-1 distribution in 3-, 6-, and 12-month-old wild-type mice and their 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 littermates. Images show
the hippocampus of wild-type (a, c, and e) and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 (b, d, and f) mice after immunostaining with endothelin-1 antibody (green) and
DAPI (blue). Images were captured at 20x magnification.
increased oxytocin immunostaining in the whole hippocam-
pus of 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice at 3 (∗∗𝑝 = 0.01), 6 (∗𝑝 = 0.04),
and 12 (∗𝑝 = 0.05) months of age (Figure 9(a)). At 6
months old,𝐶𝑎𝑡ℎ𝐴𝑆190𝐴mice showed oxytocin accumulation
in hippocampal CA1 (∗𝑝 = 0.02), CA2 (∗𝑝 = 0.03), and
CA3 (∗𝑝 = 0.05) regions (Figures 9(b), 9(c), and 9(d)). In 12-
month-old animals, significant accumulation was detected in
CA1 (∗∗𝑝 = 0.01) and CA3 (∗∗𝑝 = 0.06) (Figures 9(b) and
9(d)).
4. Conclusion
In this study, changes in learning and spatial memory were
investigated in 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice to assess the impact of the
absence of the CathA catalytic function on the processing of
two vasoactive peptides: endothelin-1 and oxytocin.
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice 3, 6, and 12 months of age were more
willing than their wild-type littermates to enter the dark
chamber in the shuttle box test, despite previous foot shocks
8 Behavioural Neurology
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Figure 7: Quantification of hippocampal endothelin-1 accumulation in whole hippocampus (a) and in hippocampal subregions CA1 (b),
CA2 (c), and CA3 (d). Six hippocampi from three animals per genotype were analyzed. Graph shows average fluorescence intensity ± SEM.
delivered there during passive avoidance tests. This could
be due to deficits in their inability to create fear-associated
memories. In addition, a spatial memory deficit was observed
in the Morris water maze task in the 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice
at all three ages. The hippocampus is an important brain
region governing cognitive and memory functions. Lesions,
long-term potentiation problems, such as increased levels of
vasoactive peptides, and loss-of-function genetic mutations
of signaling molecules/receptors within the hippocampus
lead to impairments in spatial learning and memory. The
increase in escape latency, distant travelled to the platform,
and proximity to target measurements observed in the
𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice as well as their failure to spend more time
in the correct quadrant during the probe trial compared
with their wild-type littermates suggested that a deficiency
in CathA enzyme activity leads to an impairment in spatial
learning and memory.
Previous in vitro analyses revealed the hydrolytic activ-
ity of CathA against various short peptides, including
endothelin-1 and oxytocin [14]. Endothelin-1 and oxytocin
have a broad range of roles in the regulation of cellu-
lar pathways promoting long-term potentiation and long-
lasting spatial memory with CREB phosphorylation in the
hippocampus [15, 16]. Therefore, we investigated whether
elevation of these peptides, as a result of abolishing CathA
hydrolytic enzyme activity, was related to the learning and
memory deficits studied in the 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mouse model.
Our immunohistochemistry results indicated that en-
dothelin-1 accumulated in hippocampus of 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴
mice, consistent with the previously reported distribution
of this peptide in the brain tissue of galactosialidosis
patients [17] and western blot analysis results derived from
knockout animal models [9]. In the central nervous system
CathA has strong peptidase activity [18]. We confirmed that
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Figure 8: Hippocampal oxytocin distribution in 3-, 6-, and 12-month-old wild-type (a, c, and e, resp.) and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 (b, d, and f, resp.)
mice. Images show the hippocampus of wild-type and 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice after immunostaining with an oxytocin antibody (green) and DAPI
(blue). Images were captured at 20x magnification.
endothelin-1 is a substrate for CathA and then showed, for
the first time, region-specific accumulation of the peptide in
hippocampus of 3-, 6-, and 12-month-old 𝐶𝑎𝑡ℎ𝐴𝑆190𝐴 mice.
To our knowledge, we are also the first to show that at
physiological levels oxytocin is another substrate for CathA,
the deficiency of which causes accumulation of oxytocin in
the hippocampus.
The present study suggests an intriguing possibility of
using endothelin-1 and oxytocin, as well as their therapeutic
analogs, as novel therapeutic targets for memory loss, such as
that seen in Alzheimer’s disease. If the role of these peptides
in memory improvement is confirmed, development of new
medical approaches to introduce oxytocin and endothelin-
1 into the central nervous system may be beneficial in
the treatment of memory loss-related diseases. In addition,
as discovery of new substrates of CathA could be used
as possible biomarkers in the treatment of cardiovascular
diseases, such as hypertension, results from these studies
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Figure 9: Quantification of hippocampal oxytocin accumulation in whole hippocampus (a) and hippocampal subregions CA1 (b), CA2 (c),
and CA3 (d). Six hippocampi from three mice per genotype were analyzed. Graph shows average fluorescence intensity ± SEM.
will allow better understanding of lysosomal enzyme-based
therapeutic approaches.
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